A service to determine how drugs work at a molecular level
eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
This study is working on a new way to understand how drugs work in our cells, which could help make drug development quicker and cheaper, ultimately leading to better treatments for patients like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Eclipse Bioinnovations INC NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-11111218 on NIH RePORTER |
What this research studies
This research focuses on developing a multi-omic service that helps identify the mechanisms by which drugs affect cellular functions. By utilizing advanced techniques such as transcriptomics and proteomics, the project aims to streamline the drug development process, making it faster and more cost-effective. Patients may benefit from this research as it seeks to enhance the understanding of drug actions, potentially leading to more effective therapies. The approach combines various biological assays to provide a comprehensive view of how drugs interact with cellular processes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that require new therapeutic interventions or those involved in clinical trials for drug testing.
Not a fit: Patients who are not currently seeking new treatments or those with conditions that are not targeted by the drugs being investigated may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective drug development, resulting in better treatment options for patients.
How similar studies have performed: Other research has shown success with similar multi-omic approaches in drug development, indicating a promising avenue for future advancements.
Where this research is happening
San Diego, United States
- Eclipse Bioinnovations INC — San Diego, United States (Active)
Researchers
- Principal investigator: Shishkin, Alexander a — Eclipse Bioinnovations INC
- Study coordinator: Shishkin, Alexander a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.